the opioid crisis. We remain committed to using all facets of our regulatory authority to lessen the impact of opioid addiction

The FINANCIAL -- While our efforts to combat COVID-19 remain at the forefront of our day-to-day activities, the U.S. Food and Drug Administration also continues its work on a number of important public health issues and, in particular, the opioid crisis. We remain